title: Transcatheter arterial chemotherapy with miriplatin for hepatocellular carcinoma patients with chronic renal failure: report of three cases.
abstract: Miriplatin is a novel lipophilic platinum complex that was developed to treat hepatocellular carcinoma (HCC). Although HCC patients frequently have coexisting chronic renal failure, little prospective data are available regarding the clinical toxicity of chemotherapeutic agents used to treat HCC patients with chronic renal failure. In a phase II study, the plasma concentration of total platinum in patients who received miriplatin was very low, and no severe renal toxicity caused by miriplatin injection was reported. Here, we present three cases of HCC with stage 4 chronic renal failure who received transcatheter arterial chemotherapy with miriplatin. All cases were male, ages 72, 84, and 83 years, and had serum creatinine levels of 2.3, 1.6, and 1.9 mg/dL, respectively. Their estimated glomerular filtration rates were 21.9, 20.3, and 22.2 mL/min, respectively. All cases were treated for unresectable HCC with transcatheter arterial chemotherapy with miriplatin. No serious adverse events were observed, and serum creatinine levels did not elevate, even in the patient who experienced renal failure caused by cisplatin administration. These results might suggest that transcatheter arterial chemotherapy with miriplatin can be safely used in HCC patients with chronic renal failure.
authors.affiliation: Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
authors.forename: Norihiro
authors.initials: N
authors.lastname: Imai
authors.forename: Kenji
authors.initials: K
authors.lastname: Ikeda
authors.forename: Yuya
authors.initials: Y
authors.lastname: Seko
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Kawamura
authors.forename: Hitomi
authors.initials: H
authors.lastname: Sezaki
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Hosaka
authors.forename: Norio
authors.initials: N
authors.lastname: Akuta
authors.forename: Masahiro
authors.initials: M
authors.lastname: Kobayashi
authors.forename: Satoshi
authors.initials: S
authors.lastname: Saitoh
authors.forename: Fumitaka
authors.initials: F
authors.lastname: Suzuki
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Yasuji
authors.initials: Y
authors.lastname: Arase
authors.forename: Hiromitsu
authors.initials: H
authors.lastname: Kumada
keywords: Chronic renal failure; Hepatocellular carcinoma; Miriplatin
references.citation: Br J Cancer. 2003 Nov 3;89(9):1614-9
references.pmid: 14583758
references.citation: Cardiovasc Intervent Radiol. 2007 Jan-Feb;30(1):6-25
references.pmid: 17103105
references.citation: Cancer Chemother Pharmacol. 2009 Aug;64(3):473-83
references.pmid: 19104812
references.citation: Jpn J Cancer Res. 1986 Jun;77(6):523-5
references.pmid: 3015851
references.citation: J Gastroenterol. 2010;45(1):60-7
references.pmid: 19655081
references.citation: Hepatology. 2001 Oct;34(4 Pt 1):671-6
references.pmid: 11584362
references.citation: Radiology. 2002 Jul;224(1):47-54
references.pmid: 12091661
references.citation: J Clin Invest. 1963 Jul;42(7):1179-92
references.pmid: 16695909
references.citation: Liver Int. 2004 Jun;24(3):210-5
references.pmid: 15189271
references.citation: Oncology. 2004;66(1):24-31
references.pmid: 15031595
references.citation: Aliment Pharmacol Ther. 2004 May 1;19(9):999-1007
references.pmid: 15113367
references.citation: Semin Liver Dis. 2010 Feb;30(1):52-60
references.pmid: 20175033
references.citation: Liver Int. 2010 Jan;30(1):77-84
references.pmid: 19818004
references.citation: Hepatology. 2003 Feb;37(2):233-43
references.pmid: 12540770
references.citation: Cancer Sci. 2009 Jan;100(1):189-94
references.pmid: 19037997
references.citation: Hepatol Res. 2009 Apr;39(4):346-54
references.pmid: 19054145
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: Invest New Drugs. 2004 Apr;22(2):169-76
references.pmid: 14739665
references.citation: Gastroenterology. 2006 Aug;131(2):461-9
references.pmid: 16890600
references.citation: Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
references.pmid: 11904577
references.citation: Am J Kidney Dis. 2009 Jun;53(6):982-92
references.pmid: 19339088
references.citation: Biol Pharm Bull. 2003 May;26(5):683-6
references.pmid: 12736512
references.citation: J Vasc Interv Radiol. 2001 Jul;12(7):847-54
references.pmid: 11435541